These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35406417)

  • 1. Simulating the Dynamic Intra-Tumor Heterogeneity and Therapeutic Responses.
    Liu Y; Feng C; Zhou Y; Shao X; Chen M
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in the Solid Cancer Cell Population and Its Consequences for Cancer Diagnostics and Treatment.
    Brychtová V; Valík V; Vojtěšek B
    Klin Onkol; 2018; 31(Suppl 2):5-13. PubMed ID: 31023018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Heterogeneity and Clonal Evolution of Tumor Cells and their Impact on Precision Cancer Medicine.
    Sabaawy HE
    J Leuk (Los Angel); 2013 Nov; 1(4):1000124. PubMed ID: 24558642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic heterogeneity in cancer.
    Guo M; Peng Y; Gao A; Du C; Herman JG
    Biomark Res; 2019; 7():23. PubMed ID: 31695915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zebrafish as a model to assess cancer heterogeneity, progression and relapse.
    Blackburn JS; Langenau DM
    Dis Model Mech; 2014 Jul; 7(7):755-62. PubMed ID: 24973745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of breast cancer: etiology and clinical relevance.
    Almendro V; Fuster G
    Clin Transl Oncol; 2011 Nov; 13(11):767-73. PubMed ID: 22082639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long range personalized cancer treatment strategies incorporating evolutionary dynamics.
    Yeang CH; Beckman RA
    Biol Direct; 2016 Oct; 11(1):56. PubMed ID: 27770811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
    Kim JY; Gatenby RA
    Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tracing Clonal Dynamics Reveals that Two- and Three-dimensional Patient-derived Cell Models Capture Tumor Heterogeneity of Clear Cell Renal Cell Carcinoma.
    Bolck HA; Corrò C; Kahraman A; von Teichman A; Toussaint NC; Kuipers J; Chiovaro F; Koelzer VH; Pauli C; Moritz W; Bode PK; Rechsteiner M; Beerenwinkel N; Schraml P; Moch H
    Eur Urol Focus; 2021 Jan; 7(1):152-162. PubMed ID: 31266731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-tumour heterogeneity - going beyond genetics.
    Caiado F; Silva-Santos B; Norell H
    FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Diversity in Normal Cell Populations is the Earliest Stage of Oncogenesis Leading to Intra-Tumor Heterogeneity.
    Howk CL; Voller Z; Beck BB; Dai D
    Front Oncol; 2013; 3():61. PubMed ID: 23577323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Cancer Intra-Tumor Heterogeneity: One Tumor, Different Entities.
    Esparza-López J; Escobar-Arriaga E; Soto-Germes S; Ibarra-Sánchez MJ
    Rev Invest Clin; 2017; 69(2):66-76. PubMed ID: 28453505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Methylation and Intra-Clonal Heterogeneity: The Chronic Myeloid Leukemia Model.
    Lebecque B; Bourgne C; Vidal V; Berger MG
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential Roles and Advantages of Single Cell Sequencing in the Diagnosis and Treatment of Hematological Malignancies.
    Shi M; Dong X; Huo L; Wei X; Wang F; Sun K
    Adv Exp Med Biol; 2018; 1068():119-133. PubMed ID: 29943300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer intra-tumor heterogeneity.
    Martelotto LG; Ng CK; Piscuoglio S; Weigelt B; Reis-Filho JS
    Breast Cancer Res; 2014 May; 16(3):210. PubMed ID: 25928070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hiding in Plain Sight: Epigenetic Plasticity in Drug-Induced Tumor Evolution.
    Sharma A
    Epigenet Insights; 2019; 12():2516865719870760. PubMed ID: 31453434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-tumor heterogeneity in TP53 null High Grade Serous Ovarian Carcinoma progression.
    Mota A; Triviño JC; Rojo-Sebastian A; Martínez-Ramírez Á; Chiva L; González-Martín A; Garcia JF; Garcia-Sanz P; Moreno-Bueno G
    BMC Cancer; 2015 Nov; 15():940. PubMed ID: 26620706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour Models.
    Shembrey C; Smith J; Grandin M; Williams N; Cho HJ; Mølck C; Behrenbruch C; Thomson BN; Heriot AG; Merino D; Hollande F
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics between cancer cell subpopulations reveals a model coordinating with both hierarchical and stochastic concepts.
    Wang W; Quan Y; Fu Q; Liu Y; Liang Y; Wu J; Yang G; Luo C; Ouyang Q; Wang Y
    PLoS One; 2014; 9(1):e84654. PubMed ID: 24416258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between Clonal Evolution and Drug Resistance in Bladder Cancer: A Genomic Research Review.
    Tuo Z; Zhang Y; Li D; Wang Y; Wu R; Wang J; Yu Q; Ye L; Shao F; Wusiman D; Yang Y; Yoo KH; Ke M; Okoli UA; Cho WC; Heavey S; Wei W; Feng D
    Pharmacol Res; 2024 Jul; ():107302. PubMed ID: 39004242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.